EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PTPN21 inhibits cell apoptosis of acute lymphoblastic leukemia induced by chemotherapeutic agents via GADD45A and JNK signaling pathway

Chenze Zhao, Yu Zhang, Linlin Huang, Jingjing Xiang, Baodong Ye, Ni Zhu iD

PLOS One · 2025

DOI: 10.1371/journal.pone.0322273 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Chenze Zhao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Heart Center, Department of Cardiovascular Medicine, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, H…. Hauptthemen laut MEDLINE: Apoptosis, Precursor Cell Lymphoblastic Leukemia-Lymphoma, MAP Kinase Signaling System, Cell Cycle Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Zhejiang Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute lymphoblastic leukemia (ALL), a hematologic malignancy characterized by the uncontrolled proliferation of immature lymphocytes, often results in unfavorable long-term survival prospects for patients. PTPN21, a protein with established roles in oncogenesis, has been implicated in the pathogenesis of ALL. This study explores the role of PTPN21 in ALL cell apoptosis induced by chemotherapeutic agents. Key findings reveal that elevated PTPN21 levels hinder the apoptosis of ALL cells in response to vincristine (VCR) and daunorubicin (DNR). PTPN21 accomplishes this by inhibiting the GADD45A and JNK signaling pathways, thereby reversing cell cycle arrest in the G2/M phase. Restoring GADD45A reverses the anti-apoptotic effect of PTPN21. These findings suggest that targeting PTPN21 in conjunction with chemotherapy may represent a novel therapeutic strategy for ALL, offering potential implications for improving treatment efficacy and overcoming drug resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ApoptosisPrecursor Cell Lymphoblastic Leukemia-LymphomaMAP Kinase Signaling SystemCell Cycle ProteinsAntineoplastic AgentsNuclear ProteinsHumansCell Line, TumorVincristineDaunorubicinSignal TransductionGADD45 Proteins

Substanzen

GADD45A protein, humanCell Cycle ProteinsAntineoplastic AgentsVincristineNuclear ProteinsDaunorubicinGADD45 Proteins

Autor:innen und Institutionen

  • Heart Center, Department of Cardiovascular Medicine, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China.
  • Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, China.

ORCID-Profile: Ni Zhu

Förderung

  • Natural Science Foundation of Zhejiang Province
  • National Natural Science Foundation of China

Zitieren

APA

Zhao, C., Zhang, Y., Huang, L., Xiang, J., Ye, B., & Zhu, N. (2025). PTPN21 inhibits cell apoptosis of acute lymphoblastic leukemia induced by chemotherapeutic agents via GADD45A and JNK signaling pathway. PLOS One. https://doi.org/10.1371/journal.pone.0322273

Vancouver

Zhao C, Zhang Y, Huang L, Xiang J, Ye B, Zhu N. PTPN21 inhibits cell apoptosis of acute lymphoblastic leukemia induced by chemotherapeutic agents via GADD45A and JNK signaling pathway. PLOS One. 2025. doi:10.1371/journal.pone.0322273

BibTeX
@article{Zhao2025,
  author = {Zhao, Chenze and Zhang, Yu and Huang, Linlin and Xiang, Jingjing and Ye, Baodong and Zhu, Ni},
  title = {PTPN21 inhibits cell apoptosis of acute lymphoblastic leukemia induced by chemotherapeutic agents via GADD45A and JNK signaling pathway},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0322273}
}
Kostenlos starten →